Po‐Heng Chuang

601 total citations
33 papers, 433 citations indexed

About

Po‐Heng Chuang is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Po‐Heng Chuang has authored 33 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 25 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Po‐Heng Chuang's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (18 papers). Po‐Heng Chuang is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (18 papers). Po‐Heng Chuang collaborates with scholars based in Taiwan, China and United States. Po‐Heng Chuang's co-authors include Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Sheng‐Hung Chen, Yufen Li, Wen-Pang Su, Hung‐Wei Wang, I‐Ping Chiang, Chia‐Hsin Lin and Wei‐Fan Hsu and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Po‐Heng Chuang

32 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Heng Chuang Taiwan 13 301 289 51 36 33 33 433
Kazuyuki Mizuno Japan 11 221 0.7× 215 0.7× 72 1.4× 73 2.0× 31 0.9× 41 381
Hannah M. Lee United States 11 286 1.0× 254 0.9× 25 0.5× 69 1.9× 22 0.7× 24 405
Yuta Wakui Japan 13 276 0.9× 199 0.7× 48 0.9× 88 2.4× 33 1.0× 23 467
B.E. Annicchiarico Italy 11 313 1.0× 372 1.3× 45 0.9× 71 2.0× 15 0.5× 29 524
Zhandong Li China 11 205 0.7× 181 0.6× 36 0.7× 37 1.0× 19 0.6× 15 317
Sujan Ravi United States 8 277 0.9× 233 0.8× 20 0.4× 59 1.6× 34 1.0× 18 402
Pir Ahmad Shah United States 9 191 0.6× 125 0.4× 29 0.6× 78 2.2× 34 1.0× 23 338
Barbara Lei Italy 8 153 0.5× 143 0.5× 30 0.6× 49 1.4× 19 0.6× 9 257
Ken Nishino Japan 10 314 1.0× 239 0.8× 27 0.5× 55 1.5× 13 0.4× 37 433
Shumei Lin China 14 308 1.0× 270 0.9× 28 0.5× 86 2.4× 19 0.6× 39 506

Countries citing papers authored by Po‐Heng Chuang

Since Specialization
Citations

This map shows the geographic impact of Po‐Heng Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Heng Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Heng Chuang more than expected).

Fields of papers citing papers by Po‐Heng Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Heng Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Heng Chuang. The network helps show where Po‐Heng Chuang may publish in the future.

Co-authorship network of co-authors of Po‐Heng Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Heng Chuang. A scholar is included among the top collaborators of Po‐Heng Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Heng Chuang. Po‐Heng Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yang-Hsiang, Yu‐De Chu, Kwang‐Huei Lin, et al.. (2025). HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression. Cancer Cell International. 25(1). 223–223. 1 indexed citations
2.
Wang, Hung‐Wei, Chi-Yi Chen, Hsueh‐Chou Lai, et al.. (2023). Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.. PubMed. 13(2). 526–537. 2 indexed citations
3.
4.
Hsu, Wei‐Fan, Hsueh‐Chou Lai, Po‐Heng Chuang, et al.. (2022). Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents. Journal of Viral Hepatitis. 29(9). 785–794. 4 indexed citations
5.
Liu, Chien-Ting, Yu‐Li Su, Cheng‐Hsu Wang, et al.. (2020). Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. Journal of Clinical Medicine. 9(1). 188–188. 19 indexed citations
6.
Tsai, Fuu‐Jen, Chao‐Jung Chen, Ju‐Pi Li, et al.. (2020). Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan. BMC Complementary Medicine and Therapies. 20(1). 221–221. 9 indexed citations
7.
Peng, Cheng‐Yuan, et al.. (2020). Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib. PLoS ONE. 15(12). e0244293–e0244293. 7 indexed citations
8.
9.
Tsai, Fuu‐Jen, Xiang Liu, Chao‐Jung Chen, et al.. (2019). Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan. Complementary Therapies in Medicine. 47. 102213–102213. 20 indexed citations
10.
Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2019). Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents. BMC Gastroenterology. 19(1). 63–63. 45 indexed citations
11.
Tsai, Fuu‐Jen, Chi‐Fung Cheng, Chao‐Jung Chen, et al.. (2018). Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan. Phytomedicine. 57. 30–38. 20 indexed citations
12.
Chen, Sheng‐Hung, Hsueh‐Chou Lai, I‐Ping Chiang, et al.. (2018). Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(1). e0190455–e0190455. 22 indexed citations
13.
Wang, Hung‐Wei, Hsueh‐Chou Lai, Tsung‐Hui Hu, et al.. (2018). Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy. Journal of Gastroenterology and Hepatology. 34(2). 442–449. 11 indexed citations
14.
Lin, Che-Chen, Cheng‐Yuan Peng, Po‐Heng Chuang, et al.. (2017). Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?. Medicine. 96(34). e7785–e7785. 11 indexed citations
15.
Peng, Cheng‐Yuan, Hsueh‐Chou Lai, Wen-Pang Su, et al.. (2017). Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B. Scientific Reports. 7(1). 42879–42879. 17 indexed citations
16.
Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2017). Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long‐term nucleos(t)ide analogue therapy. Liver International. 38(4). 627–635. 4 indexed citations
17.
Chen, Sheng‐Hung, Cheng‐Yuan Peng, I‐Ping Chiang, et al.. (2016). Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C. Medicine. 95(35). e4736–e4736. 8 indexed citations
18.
Chen, Sheng‐Hung, Cheng‐Yuan Peng, Hsueh‐Chou Lai, et al.. (2015). Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C. PLoS ONE. 10(10). e0140554–e0140554. 13 indexed citations
19.
Chen, Sheng‐Hung, Yufen Li, Hsueh‐Chou Lai, et al.. (2012). Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. BMC Gastroenterology. 12(1). 105–105. 44 indexed citations
20.
Jeng, Long‐Bin, et al.. (2008). Polytetrafluoroethylene Patch Venoplasty for Outflow Reconstruction in Living Donor Liver Transplantation: Two Case Reports. Transplantation Proceedings. 40(8). 2529–2530. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyuki Mizuno Breakdown of academic impact, for papers by Hannah M. Lee Breakdown of academic impact, for papers by Yuta Wakui Breakdown of academic impact, for papers by B.E. Annicchiarico Breakdown of academic impact, for papers by Zhandong Li Breakdown of academic impact, for papers by Sujan Ravi Breakdown of academic impact, for papers by Pir Ahmad Shah Breakdown of academic impact, for papers by Barbara Lei Breakdown of academic impact, for papers by Ken Nishino Breakdown of academic impact, for papers by Shumei Lin
Rankless by CCL
2026